This Year's Sponsors

Honeywell Life Sciences, the makers of TrackWise, are on a mission to accelerate innovation for a healthier future. From manufacturing life-saving drugs to safeguarding supply chain continuity, Life Sciences organizations partner with Honeywell to solve their most critical challenges and drive meaningful patient and business outcomes. Honeywell empower Life Science companies with the latest innovation to improve operational efficiency and bring safer products to market faster, by automating and optimizing their manufacturing and supply chain eco-system. Life Sciences companies worldwide trust Honeywell for the advanced technology solutions and domain expertise they need to drive continuous business improvements while helping them make smarter faster decisions about the things that matter most.

MasterControl Inc. provides cloud-based software to empower manufacturers in life sciences and other regulated industries simplify manufacturing execution. Our mission is to help our customers bring life-changing products to more people sooner. Learn how to take a smarter approach to manufacturing at mastercontrol.com.

Regenity Biosciences, a Linden Capital Partners portfolio company, is a leading global developer and manufacturer of bioresorbable technologies to repair and regenerate natural tissue and bone for a variety of markets including dental, spine, orthopedic, sports medicine, advanced wound, neurosurgery, ENT, and nerve repair. Founded in 1997, Regenity (formerly Collagen Matrix, Inc.) is headquartered in Paramus, New Jersey, with manufacturing locations in Oakland and Allendale, New Jersey and Groningen, the Netherlands. Regenity’s product portfolio includes a variety of collagen-based and synthetic polymer solutions that support the company’s platform for tissue and bone regeneration. Regenity develops proprietary products that are sold to OEM customers on either a contract or private label basis and offers partnership opportunities including contract product development and manufacturing services. For more information, please visit www.regenity.com.

The Voluntary Improvement Program (VIP) helps device makers design, build and deliver safer products to patients, faster. Developed in collaboration with FDA, MDIC, ISACA and the medical device industry as part of the FDA’s case for quality initiative, this program identifies process inefficiencies and helps device makers implement best practices that accelerate medical device improvements. Participant outcomes include increased speed to market, improved production capacity, reduced regulatory burden & more.

Eligible participants also benefit from several FDA opportunities to help accelerate improvements to device quality and manufacturing by means of modified inspection planning and bundled PMA and Site Change submissions with reduced review timeframes, all detailed in the FDA Guidance “Fostering Medical Device Improvement: FDA Activities and Engagement with the Voluntary Improvement Program” released in September 2023.